Dow Jones

39,902.46

0.08%

Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Get Started

Cortexyme (CRTX)

Cortexyme Inc

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:CRTX

1 2 Next >>

Date	Time	Source	Headline	Symbol	Company
26/05/2023	22:51	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CRTX	Cortexyme Inc
26/05/2023	22:50	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CRTX	Cortexyme Inc
25/05/2023	21:26	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CRTX	Cortexyme Inc
14/04/2023	21:13	Edgar (US Regulatory)	Annual Report to Security Holders (ars)	NASDAQ:CRTX	Cortexyme Inc
14/04/2023	21:07	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:CRTX	Cortexyme Inc
05/04/2023	22:16	Edgar (US Regulatory)	Securities Registration (section 12(b)) (8-a12b)	NASDAQ:CRTX	Cortexyme Inc
31/03/2023	21:01	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:CRTX	Cortexyme Inc
28/03/2023	22:05	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CRTX	Cortexyme Inc
15/03/2023	21:07	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:CRTX	Cortexyme Inc
03/03/2023	21:17	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CRTX	Cortexyme Inc
13/02/2023	22:29	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:CRTX	Cortexyme Inc
02/02/2023	23:38	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CRTX	Cortexyme Inc
02/02/2023	23:36	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CRTX	Cortexyme Inc
02/02/2023	23:33	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CRTX	Cortexyme Inc
02/02/2023	23:30	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CRTX	Cortexyme Inc
16/12/2022	21:04	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CRTX	Cortexyme Inc
07/12/2022	22:38	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CRTX	Cortexyme Inc
09/11/2022	21:26	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:CRTX	Cortexyme Inc
08/09/2022	22:59	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CRTX	Cortexyme Inc
18/12/2009	18:45	PR Newswire (US)	Cornerstone Therapeutics to Host Conference Call to Discuss Financial Guidance for 2010	NASDAQ:CRTX
20/11/2009	20:40	PR Newswire (US)	Cornerstone Therapeutics Provides a Response to FDA Warning Letter on Deconsal	NASDAQ:CRTX
16/11/2009	13:00	PR Newswire (US)	Cornerstone Therapeutics to Present at the 6th Annual Lazard Capital Markets Healthcare Conference	NASDAQ:CRTX
13/11/2009	13:00	PR Newswire (US)	Cornerstone Therapeutics Appoints General Counsel	NASDAQ:CRTX
04/11/2009	12:00	PR Newswire (US)	Cornerstone Therapeutics Reports Third Quarter 2009 Financial Results	NASDAQ:CRTX
21/10/2009	13:00	PR Newswire (US)	Cornerstone Therapeutics to Host Third Quarter 2009 Conference Call	NASDAQ:CRTX
03/09/2009	13:01	PR Newswire (US)	Cornerstone Therapeutics Receives Approval to Acquire Commercial Rights to the Antibiotic Factive(R)	NASDAQ:CRTX
03/09/2009	13:00	PR Newswire (US)	Cornerstone Therapeutics to Present at Two Upcoming Investor Conferences	NASDAQ:CRTX
20/07/2009	13:00	PR Newswire (US)	Cornerstone Therapeutics' David Price Named 2009 Chief Financial Officer of the Year by the Triangle Business Journal	NASDAQ:CRTX
16/07/2009	00:04	PR Newswire (US)	Cornerstone Therapeutics Submits Regulatory Filing for Extended-Release Antitussive Product	NASDAQ:CRTX
08/07/2009	21:15	PR Newswire (US)	Cornerstone Therapeutics Inc. Announces Record Date and Meeting Date for Special Meeting of Stockholders for Vote with Respect t	NASDAQ:CRTX